Beranda › Leiomyosarcoma › Texas › Houston
Uji klinis Leiomyosarcoma di Houston, TX
7 studi untuk Leiomyosarcoma mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Menerima pesertaFase 1/2
- UT MD Anderson Cancer Center, Houston
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Menerima pesertaFase 3
- M D Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Menerima pesertaFase 1
- UT MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Menerima pesertaFase 1/2
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Metastatic Leiomyosarcoma Biomarker Protocol
Menerima pesertaStudi observasional
- MD Anderson, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Menerima pesertaFase 1
- MD Anderson Cancer Center, Houston
Uji klinis Leiomyosarcoma di kota lain
- Boston, MA5 studi
- Santa Monica, CA4 studi
- Chicago, IL4 studi
- Rochester, MN3 studi
- New York City, NY3 studi
- Nashville, TN3 studi
- Ann Arbor, MI3 studi
- Columbus, OH3 studi
- Queens, NY3 studi
- Aurora, CO3 studi
- St. Louis, MO3 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.